You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

A Provider’s Guide to Detecting Alpha-1 Antitrypsin Deficiency

  • Authors: James Michael Wells, MD; Cheryl S. Pirozzi, MD; Ross C. Schumacher, MD; deNay Porter Kirkpatrick, DNP; Monica Goldklang, MD
  • CME / ABIM MOC / CE Released: 1/6/2022
  • Valid for credit through: 1/6/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.75 ABIM MOC points

    Nurses - 0.75 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    IPCE - 0.75 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for gastroenterologists, pulmonologists, and allergists and immunologists.

The goal of this activity is to increase the percentage of patients who are appropriately tested for alpha-1 antitrypsin (AAT) by improving clinician performance in testing individuals with a high probability of AATD (AAT deficiency) and educating patients/caregivers of individuals who have a high likelihood of having AATD.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Treatment options for AATD
  • Demonstrate improved performance associated with
    • Testing priority populations for AATD
    • Identification of individuals who are more likely to have AATD
    • Implementation of a care-team approach to increasing AATD screening


Faculty

  • James Michael Wells, MD

    Associate Professor of Pulmonary, Allergy, & Critical Care Medicine
    Department of Medicine
    The University of Alabama at Birmingham
    Birmingham, Alabama

    Disclosures

    Disclosure: James Michael Wells, MD, has the following relevant financial relationships:
    Advisor or consultant for: AstraZeneca; Mereo Biopharma; Takeda
    Grants for clinical research from: ARCUS-MED; Bayer AG; BioPharma; Grifols; Mereo BioPharma; Verona; Vertex Pharmaceuticals

  • Cheryl S. Pirozzi, MD

    Associate Professor
    Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine
    University of Utah Health Sciences Center
    Salt Lake City, Utah

    Disclosures

    Disclosure: Cheryl S. Pirozzi, MD, has the following relevant financial relationships:
    Grants for clinical research from: Vertex

  • Ross C. Schumacher, MD

    Pulmonary Fellow
    Pulmonary, Allergy, & Critical Care Medicine
    Department of Medicine
    The University of Alabama at Birmingham
    Birmingham, Alabama

    Disclosures

    Disclosure: Ross C. Schumacher, MD, has no relevant financial relationships.

  • deNay Porter Kirkpatrick, DNP

    Pulmonary Nurse Practitioner
    Department of Medicine
    The University of Alabama at Birmingham
    Birmingham, Alabama

    Disclosures

    Disclosure: deNay Porter Kirkpatrick, DNP, has no relevant financial relationships.

  • Monica Goldklang, MD

    Assistant Professor of Medicine Pulmonary and Critical Care Medicine
    Columbia University Irving Medical Center
    New York, New York

    Disclosures

    Disclosure: Monica Goldberg, MD, has the following relevant financial relationships:
    Advisor or consultant for: Takeda
    Grants for clinical research from: Arrowhead; CSL Behring; Grifols; Vertex

Editors

  • Pakinam Aboulsaoud, PharmD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Pakinam Aboulsaoud, PharmD, has disclosed no relevant financial relationships.

  • Yoji Yamaguchi, MA, ELS

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Yoji Yamaguchi, MA, ELS, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Mitigation

All of the relevant financial relationships listed for these individuals have been mitigated.


Accreditation Statements

Developed through a partnership between Medscape and University of Alabama.



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

A Provider’s Guide to Detecting Alpha-1 Antitrypsin Deficiency

Authors: James Michael Wells, MD; Cheryl S. Pirozzi, MD; Ross C. Schumacher, MD; deNay Porter Kirkpatrick, DNP; Monica Goldklang, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 1/6/2022

Valid for credit through: 1/6/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Missing Opportunities in AATD

Dr Wells reviews the epidemiology of AATD and the causes and consequences of diagnostic delay.
James Michael Wells, MD

Suspicious Symptomology in AATD

Dr Pirozzi offers a primer on identifying patients with AATD and AATD-associated lung disease.
Cheryl S. Pirozzi, MD

Diagnostic Decisions in AATD: Patient Cases

Dr Schumacher uses 3 patient cases to illustrate best practices in AATD screening.
Ross C. Schumacher, MD

Implementing a Care-Team Approach in AATD Screening

Dr Kirkpatrick discusses the multidisciplinary care-team approach to screening patients for AATD.
deNay Porter Kirkpatrick, DNP

Communicating Quality Care in AATD

Dr Goldklang reviews critical first steps in the care of patients who have been diagnosed with AATD.
Monica P. Goldklang, MD
 

Assessment Survey

Before you begin, please take this brief survey.